Weight loss with semaglutide injections works well for many people, but this treatment is not suitable for everyone
The minimum commitment is three months to ensure safe and effective results
The NHS has approved Wegovy for use in adults who meet all of the following criteria: It is also worth noting that due to high demand and ongoing supply constraints, NHS access to Wegovy has been phased in gradually, meaning waiting times can be lengthy and availability may vary depending on your local area
Among insurers that may cover these medications are UnitedHealthcare, Cigna, Blue Cross Blue Shield, Aetna, Medicare Part D, and Medicaid (state-dependent)
Backed by Science and FDA-Approved Semaglutide is extensively researched, FDA-approved, and considered safe when used under medical supervision
The FDA confirmed in February 2025 that compounded semaglutide remains legal through 503A pharmacies for patients with documented medical need (allergy, non-commercial strength, or different delivery route), but warned 30 telehealth companies against illegal marketing of compounded GLP-1s [3]